TrumpRx

News

In brief SOTU remarks, Trump asks Congress to "codify" MFN

In a speech at least nominally focused on the economy and affordability, President Trump put surprisingly little emphasis on his drug pricing efforts.

News

White House's TrumpRx platform has arrived

The Trump administration's long-promised direct-to-consumer (DTC) sales channel for medicines, TrumpRx, has finally gone live.

News

Nine more companies sign pricing deals with Trump

Nine more pharma groups have agreed to lower the costs of medicines in the US under the Trump administration's most favoured nation (MFN) scheme.

Market Access

Policy in Focus: Trump’s MFN deals, FDA vouchers, and the go...

Policy experts Alice Valder Curran and Elizabeth Jungman of Hogan Lovells weigh in on Trump's MFN deals, FDA vouchers, and the government shutdown.

News

Merck joins the Trump MFN gang with IVF deal

Merck KGaA has become the third drugmaker to reach a deal with the Trump administration to cut medicine costs, offering discounts on fertility drugs.

News

AstraZeneca joins Pfizer in MFN pricing deal with US

AstraZeneca has become the second pharma group to reach an agreement with the Trump administration on Most Favoured Nation (MFN) drug pricing.

In brief SOTU remarks, Trump asks Congress to "codify" MFN

White House's TrumpRx platform has arrived

Nine more companies sign pricing deals with Trump

Policy in Focus: Trump’s MFN deals, FDA vouchers, and the go...

Merck joins the Trump MFN gang with IVF deal

AstraZeneca joins Pfizer in MFN pricing deal with US

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Using AI-driven synthetic personas to take your insights fur...

TrumpRx

Editor's Picks